Depósito Digital de Documentos de la UAB Encontrados 36 registros  1 - 10siguientefinal  ir al registro: La búsqueda tardó 0.00 segundos. 
1.
30 p, 1.5 MB The Nexus of COVID-19 and Climate Change : A Systematic Literature Review / Mestre Garcia, Carolina (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; Savin, Ivan (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ; van den Bergh, Jeroen C. J. M (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals)
Since the onset of the COVID-19 pandemic, many studies have appeared on how it will affect climate change and policy, and vice versa. In this study, we systematically review the literature about this relationship. [...]
2023 - 10.1515/jbnst-2023-0048
Jahrbucher fur Nationalokonomie und Statistik, (November 2023)  
2.
9 p, 694.0 KB Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment : Data from the BIOBADASER III register / Vela, Paloma (ISABIAL) ; Sanchez-Piedra, Carlos (Unidad de Investigación ser) ; Pérez-García, Carolina (Hospital del Mar (Barcelona, Catalunya)) ; Castro-Villegas, María C. (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ; Freire, Mercedes (Hospital A Coruña) ; Mateo, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ; Bohórquez, Cristina (Hospital Príncipe de Asturias) ; Blanco-Madrigal, Juan M. (Hospital de Basurto (Bilbao, Biscaia)) ; Ros-Vilamajo, Inmaculada (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Gómez, Silvia (ISABIAL) ; Caño, Rocio (ISABIAL) ; Sánchez-Alonso, Fernando (Unidad de Investigación ser) ; Díaz-González, Federico (Hospital Universitario de Canarias (La Laguna)) ; Gómez-Reino, Juan J. (Hospital de Santiago) ; Universitat Autònoma de Barcelona
To assess whether age, at the beginning of biologic treatment, is associated with the time a first adverse event (AE) appears in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), or psoriatic arthritis (PsA). [...]
2020 - 10.1186/s13075-020-02231-x
Arthritis research & therapy, Vol. 22 Núm. 1 (15 2020) , p. 143  
3.
10 p, 1.1 MB Heterogeneity in the association between prediabetes categories and reduction on glomerular filtration rate in a 5-year follow-up / Manouchehri, Marjan ; Cea-Soriano, Lucía (Universidad Complutense de Madrid) ; Franch-Nadal, Josep (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Ruiz, Antonio (Universidad Europea de Madrid) ; Goday Arnó, Albert (Hospital del Mar (Barcelona, Catalunya)) ; Villanueva, Rosa (Universidad Complutense de Madrid) ; Diez-Espino, Javier (Instituto de Investigación Sanitaria de Navarra) ; Mata-Cases, Manel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Giraldez-García, Carolina (Hospital Universitario del Tajo) ; Regidor, Enrique (CIBER Epidemiología Y Salud Pública (CIBERESP)) ; Tarragó, Eduard (Hospital Universitari de Bellvitge) ; Universitat Autònoma de Barcelona
Prediabetes and not just diabetes can cause kidney damage. This study assess the association of prediabetes with development of impaired renal function (IRF). We used data from PREDAPS prospective study a cohort of 1072 subjects with prediabetes and another cohort of 772 subjects without prediabetes were follow-up from 2012 to 2017. [...]
2022 - 10.1038/s41598-022-11392-5
Scientific reports, Vol. 12 (may 2022)  
4.
6 p, 3.4 MB Outcome of infection with omicron -2 variant in patients with hematological malignancies : An survey report / Blennow, Ola (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Salmanton-García, Jon (University of Cologne) ; Nowak, Piotr (Karolinska Institutet (Suecia)) ; Itri, Federico (San Luigi Gonzaga Hospital - Orbassano) ; van Doesum, Jaap A (Department of Hematology, University Medical Center Groningen) ; López-García, Alberto (Fundacion Jimenez Diaz University Hospital) ; Farina, Francesca (Istituto Scientifico San Raffaele) ; Jakšić, Ozren (University Hospital Dubrava) ; Pinczés, László Imre (University of Debrecen) ; Bilgin, Yavuz M. (ADRZ) ; Falces-Romero, Iker (Instituto de Salud Carlos III) ; Jiménez, Moraima (Vall d'Hebron Institut d'Oncologia) ; Ormazabal-Vélez, Irati (Complejo Hospitalario de Navarra) ; Weinbergerová, Barbora (University Hospital Brno (República Txeca)) ; Duléry, Rémy (Sorbonne Université) ; Stojanoski, Zlate (University of Skopje) ; Lahmer, Tobias (TU München) ; Fernández, Noemí (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Hernández-Rivas, José-Ángel (Hospital Universitario Infanta Leonor) ; Petzer, Verena (Medical University of Innsbruck) ; De Jonge, Nick (Vrije Universiteit Amsterdam) ; Glenthøj, Andreas (Copenhagen University Hospital Rigshospitalet) ; De Ramón-Sánchez, Cristina (Instituto de Investigación Biomédica de Salamanca) ; Biernat, Monika M. (Wroclaw Medical University) ; Fracchiolla, Nicola (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Aujayeb, Avinash (Northumbria Healthcare) ; Van Praet, Jens (AZ Sint-Jan Brugge-Oostende AV) ; Schönlein, Martin (University Medical Center Hamburg-Eppendorf) ; Méndez, Gustavo-Adolfo (Hospital Escuela de Agudos Dr. Ramón Madariaga) ; Cattaneo, Chiara (ASST-Spedali Civili) ; Guidetti, Anna (Fondazione IRCCS Istituto Nazionale dei Tumori) ; Sciumè, Mariarita (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Ammatuna, Emanuele (University Medical Center Groningen) ; Cordoba, Raul (Fundacion Jimenez Diaz University Hospital) ; García-Poutón, Nicole (Hospital Clínic i Provincial de Barcelona) ; Gräfe, Stefanie (Universitätsklinikum Hamburg Eppendorf) ; Cabirta, Alba (Vall d'Hebron Institut d'Oncologia) ; Wolf, Dominik (Medical University of Innsbruck) ; Nordlander, Anna (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; García-Sanz, Ramón (Instituto de Investigación Biomédica de Salamanca) ; Delia, Mario (AOUC Policlinico) ; Berg Venemyr, Caroline (Copenhagen University Hospital Rigshospitalet) ; Brones, Clara (Centre Hospitalier de Versailles) ; Di Blasi, Roberta (Hopital Saint Louis) ; De Kort, Elizabeth (Radboud University Medical Center) ; Meers, Stef (AZ KLINA) ; Lamure, Sylvain (University Hospital of Montpellier (França)) ; Serrano, Laura (Hospital Universitario de Cabueñes (Gijón)) ; Merelli, Maria (ASU FC Udine Hospital) ; Coppola, Nicola (Universitry of Campania) ; Bergantim, Rui (Centro Hospitalar e Universitário de São João) ; Besson, Caroline (Centre Hospitalier de Versailles) ; Kohn, Milena (Centre Hospitalier de Versailles) ; Petiti, Jessica (University of Turin) ; Garcia-Vidal, Carolina (Hospital Clínic i Provincial de Barcelona) ; Dargenio, Michelina ("Vito Fazzi" Hospital) ; Danion, François (CHU de Strasbourg) ; Machado, Marina (Hospital General Universitario Gregorio Marañón) ; Bailén, Rebeca (Hospital General Universitario Gregorio Marañón) ; Hoenigl, Martin (Medical University of Graz) ; Dragonetti, Giulia (Fondazione Policlinico Universitario Agostino Gemelli) ; Chai, Louis Yi Ann (National University Health System) ; Kho, Chi Shan (Pamela Youde Nethersole Eastern Hospital) ; Bonanni, Matteo (Università Cattolica del Sacro Cuore) ; Liévin, Raphaël (Hopital Saint Louis) ; Marchesi, Francesco (IRCCS Regina Elena National Cancer Institute) ; Cornely, Oliver A. (German Centre for Infection Research) ; Pagano, Livio (Università Cattolica del Sacro Cuore) ; Universitat Autònoma de Barcelona
2022 - 10.1002/ajh.26626
American Journal of Hematology, Vol. 97 (june 2022) , p. E312-E317  
5.
16 p, 2.3 MB Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis / Julià Cano, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gómez, A. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; López-Lasanta, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Blanco-García, F.J (Complejo Hospitalario Universitario de A Coruña) ; Erra, Alba (Hospital de San Rafael (Madrid). Servicio de Reumatología) ; Fernández-Nebro, Antonio (Hospital Regional Universitario de Málaga) ; Mas, Antonio Juab (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Pérez-García, Carolina (Hospital del Mar (Barcelona, Catalunya)) ; García Vivar, Ma Luz (Hospital Universitario Basurto. Servicio de Reumatología) ; Sánchez-Fernández, Simón (Hospital General La Mancha Centro. Servicio de Reumatología) ; Alperi-López, Mercedes (Hospital Universitario Central de Asturias) ; Sanmartí, Raimon (Fundació Clínic. Servei de Reumatologia) ; Ortiz, Ana María (Hospital Universitario de La Princesa. Servicio de Reumatología) ; Fernandez-Cid, Carlos Marras (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ; Moreno Ruzafa, Estefanía (Consorci Sanitari de l'Alt Penedès. Unitat de Reumatologia) ; Li, Tianlu (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martínez-Mateu, Sergio H. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Absher, Devin M. (HudsonAlpha Institute for Biotechnology) ; Myers, Richard M. (HudsonAlpha Institute for Biotechnology) ; Tornero Molina, Jesús (Hospital Universitario de Guadalajara. Servicio de Reumatología) ; Marsal, Sara (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Background: Rheumatoid arthritis (RA) is a chronic, immune-mediated inflammatory disease of the joints that has been associated with variation in the peripheral blood methylome. In this study, we aim to identify epigenetic variation that is associated with the response to tumor necrosis factor inhibitor (TNFi) therapy. [...]
2022 - 10.1016/j.ebiom.2022.104053
EBioMedicine, Vol. 80 (june 2022) , p. 104053  
6.
8 p, 568.7 KB C-reactive protein isoforms as prognostic markers of COVID-19 severity / Molins, Blanca (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Figueras-Roca, Marc (Institut Clínic d'Oftalmologia. Hospital Clínic de Barcelona) ; Valero, Oliver (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ; Llorenç, Víctor (Institut Clínic d'Oftalmologia. Hospital Clínic de Barcelona) ; Romero-Vázquez, Sara (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Sibila, Oriol (Universitat de Barcelona. Hospital Clínic de Barcelona) ; Adan Civera, Alfredo (Institut Clínic d'Oftalmologia. Hospital Clínic de Barcelona) ; Garcia-Vidal, Carolina (Universitat de Barcelona. Hospital Clínic de Barcelona) ; Soriano, A (Universitat de Barcelona. Hospital Clínic de Barcelona)
C-reactive protein (CRP), an active regulator of the innate immune system, has been related to COVID-19 severity. CRP is a dynamic protein undergoing conformational changes upon activation in inflammatory microenvironments between pentameric and monomeric isoforms. [...]
2023 - 10.3389/fimmu.2022.1105343
Frontiers in immunology, Vol. 13 (January 2023) , art. 1105343  
7.
8 p, 696.1 KB Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study / Gómez-Puerta, José A. (Universitat de Barcelona. Departament de Medicina) ; Lobo-Prat, David (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Pérez-García, Carolina (Hospital del Mar (Barcelona, Catalunya)) ; Ponce, Andrés (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Frade-sosa, Beatriz (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Millán Arciniegas, Ana Milena (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Ojeda, Fabiola (Hospital del Mar (Barcelona, Catalunya)) ; Ruiz-Esquide, Virginia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Corominas, Hèctor (Institut d'Investigació Biomèdica Sant Pau)
Objectives: To describe different clinical patterns of rheumatic immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICI) and their rheumatic and oncologic outcomes. Methods: We classified clinical syndromes according to five different categories: non-inflammatory arthralgias (NIA), rheumatoid arthritis (RA)-like, psoriatic arthritis (PsA)-like, polymyalgia rheumatica (PMR)-like, and a miscellaneous group of patients with other syndromes. [...]
2022 - 10.3389/fmed.2022.888377
Frontiers in Medicine, Vol. 9 (June 2022) , p. 888377  
8.
15 p, 1.4 MB Critical role of interleukin (IL)-17 in inflammatory and immune disorders : An updated review of the evidence focusing in controversies / Ruiz de Morales, José María G. (Universidad de León) ; Puig, Lluís (Universitat Autònoma de Barcelona. Departament de Medicina) ; Daudén, Esteban (Hospital Universitario de la Princesa (Madrid)) ; Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ; Pablos, José Luis (Hospital Universitario 12 de Octubre (Madrid)) ; Martín, Antonio Oliveira (Hospital Universitario La Paz (Madrid)) ; Juanatey, Carlos González (Hospital Universitario Lucus Augusti (Lugo)) ; Adan Civera, Alfredo (Hospital Clínic i Provincial de Barcelona) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Borruel, Natalia (Hospital Universitari Vall d'Hebron) ; Ortí, Guillermo (Vall d'Hebron Institut d'Oncologia) ; Holgado-Martín, Esther (Ruber Internacional) ; Garcia-Vidal, Carolina (Hospital Clínic i Provincial de Barcelona) ; Vizcaya-Morales, Cynthia (Novartis Pharma) ; Martín-Vázquez, Víctor (Novartis Farmacéutica) ; González-Gay, Miguel Ángel (Universidad de Cantabria)
Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive research because of its crucial role in the pathogenesis of different diseases across many medical specialties. [...]
2020 - 10.1016/j.autrev.2019.102429
Autoimmunity Reviews, Vol. 19 Núm. 1 (january 2020) , p. 102429  
9.
12 p, 770.4 KB COVID-19 in adult acute myeloid leukemia patients : a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) / Marchesi, Francesco (IRCCS Regina Elena National Cancer Institute) ; Salmanton-García, Jon (University of Cologne) ; Emarah, Ziad (Mansoura University) ; Piukovics, Klára (Medicine University of Szeged) ; Nucci, Marcio (Federal University of Rio de Janeiro) ; López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Rácil, Zdenék (Institute of Hematology and Blood Transfusion) ; Farina, Francesca (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Popova, Marina (Pavlov University) ; Zompi, Sofia (AOU Citta' della Salute e della Scienza) ; Audisio, Ernesta (AOU Citta' della Salute e della Scienza) ; Ledoux, Marie-Pierre (Institut de Cancérologie Strasbourg Europe) ; Verga, Luisa (Università Milano-Bicocca) ; Weinbergerová, Barbora (University Hospital Brno (República Txeca)) ; Szotkovski, Tomas (University Hospital Olomouc (Olomouc, República Txeca)) ; Da Silva, Maria Gomes (Portuguese Institute of Oncology) ; Fracchiolla, Nicola (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; De Jonge, Nick (Amsterdam UMC) ; Collins, Graham (Oxford University Hospitals) ; Marchetti, Monia (Azienda Ospedaliera Nazionale "SS. Antonio e Biagio e Cesare Arrigo") ; Magliano, Gabriele (ASST Grande Ospedale Metropolitano Niguarda) ; Garcia-Vidal, Carolina (Universitat de Barcelona) ; Biernat, Monika M. (Wroclaw Medical University) ; Van Doesum, Jaap (University Medical Center Groningen) ; Machado, Marina (Hospital General Universitario Gregorio Marañón) ; Demirkan, Fatih (Dokuz Eylul University) ; Al-Khabori, Murtadha (Sultan Qaboos University Hospital) ; Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ; Víšek, Benjamín (University Hospital Hradec Kralove (República Txeca)) ; Stoma, Igor (Gomel State Medical University, Gomel) ; Méndez, Gustavo-Adolfo (Hospital Escuela de Agudos Dr. Ramón Madariaga) ; Maertens, Johan (KU Leuven) ; Khanna, Nina (University Hospital Basel (Basilea, Suïssa)) ; Espigado, Ildefonso (Universidad de Sevilla) ; Dragonetti, Giulia (Fondazione Policlinico Universitario Agostino Gemelli) ; Fianchi, Luana (Fondazione Policlinico Universitario Agostino Gemelli) ; Del Principe, Maria Ilaria (Tor Vergata University of Rome) ; Cabirta, Alba (Vall d'Hebron Institut d'Oncologia) ; Ormazabal-Vélez, Irati (Complejo Hospitalario de Navarra) ; Jakšić, Ozren (University Hospital Dubrava) ; Buquicchio, Caterina (Ematologia con Trapianto (Itàlia)) ; Bonuomo, Valentina (University of Verona) ; Batinié, Josip (University Hospital Centre Zagreb) ; Omrani, Ali S. (Hamad Medical Corporation) ; Lamure, Sylvain (Universite de Montpellier) ; Finizio, Olimpia (Università Cattolica del Sacro Cuore) ; Fernández, Noemí (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Falces-Romero, Iker (Hospital Universitario La Paz (Madrid)) ; Blennow, Ola (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Bergantim, Rui (Centro Hospitalar e Universitário São João (Portugal)) ; Ali, Natasha (Aga Khan University Hospital) ; Win, Sein (Yangon General Hospital) ; Van Praet, Jens (AZ Sint-Jan Brugge-Oostende) ; Tisi, Maria Chiara (Ospedale San Bortolo) ; Shirinova, Ayten (Azerbaijan Scientific Research Hematology and Transfusiology Institute) ; Schönlein, Martin (University Medical Center Hamburg-Eppendorf) ; Prattes, Juergen (Medical University of Graz) ; Piedimonte, Monica (AOU Sant'Andrea) ; Petzer, Verena (Medical University of Innsbruck) ; Navrátil, Milan (University Hospital of Ostrava) ; Kulasekararaj, Austin (King's College Hospital NHS Foundation Trust) ; Jindra, Pavel (University Hospital Pilsen) ; Sramek, Jirí (University Hospital Pilsen) ; Glenthøj, Andreas (Copenhagen University Hospital) ; Fazzi, Rita (Azienda Ospedaliera Università Pisana) ; De Ramón-Sánchez, Cristina (Instituto de Investigación Biomédica de Salamanca) ; Cattaneo, Chiara (ASST-Spedali Civili) ; Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ; Bahr, Nathan C. (University of Kansas Medical Center) ; El-Ashwah, Shaimaa (Mansoura University) ; Cordoba, Raul (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Hanakova, Michaela (Institute of Hematology and Blood Transfusion) ; Zambrotta, Giovanni (Azienda Ospedaliera San Gerardo) ; Zambrotta, Giovanni (Università Milano-Bicocca) ; Sciumè, Mariarita (IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Booth, Stephen (Oxford University Hospitals) ; Rodrigues, Raquel Nunes (Portuguese Institute of Oncology) ; Sacchi, Maria Vittoria (Azienda Ospedaliera Nazionale "SS. Antonio e Biagio e Cesare Arrigo") ; García-Poutón, Nicole (Universitat de Barcelona) ; Martín-González, Juan-Alberto (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Khostelidi, Sofya (North-Western State Medical University named after Iliá Ilich Méchnikov) ; Gräfe, Stefanie (University of Cologne) ; Rahimli, Laman (University of Cologne) ; Ammatuna, Emanuele (University Medical Center Groningen) ; Busca, Alessandro (AOU Citta' della Salute e della Scienza) ; Corradini, Paolo (University of Milan) ; Hoenigl, Martin (Medical University of Graz) ; Klimko, Nikolai (North-Western State Medical University named after Iliá Ilich Méchnikov) ; Koehler, Philipp (University of Cologne) ; Pagliuca, Antonio (King's College Hospital NHS Foundation Trust) ; Passamonti, Francesco (University of Insubria and ASST Sette Laghi) ; Cornely, Oliver A. (University of Cologne) ; Pagano, Livio (Università Cattolica del Sacro Cuore) ; Universitat Autònoma de Barcelona
Patients with acute myeloid leukemia (AML) are at high risk of dying from coronavirus disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not been established. Our multicenter study included 388 adult AML patients diagnosed with COVID-19 between February 2020 and October 2021. [...]
2022 - 10.3324/haematol.2022.280847
Haematologica, Vol. 108 (may 2022) , p. 22-33  
10.
16 p, 5.7 MB The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis / de la Calle-Fabregat, Carlos (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rodríguez-Ubreva, Javier (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ciudad, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ramírez, Julio (Hospital Clínic i Provincial de Barcelona) ; Celis, Raquel (Hospital Clínic i Provincial de Barcelona) ; Azuaga, Ana Belén (Hospital Clínic i Provincial de Barcelona) ; Cuervo, Andrea (Hospital Clínic i Provincial de Barcelona) ; Graell, Eduard (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Pérez-García, Carolina (Institut Hospital del Mar d'Investigacions Mèdiques) ; Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ; Salvador, Georgina (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Gómez-Puerta, Jose A. (Hospital Clínic i Provincial de Barcelona) ; Haro, Isabel (Institut de Química Avançada de Catalunya) ; Sanmartí, Raimon (Hospital Clínic i Provincial de Barcelona) ; Cañete, Juan D (Hospital Clínic i Provincial de Barcelona) ; Ballestar, Esteban (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Identifying predictive biomarkers at early stages of inflammatory arthritis is crucial for starting appropriate therapies to avoid poor outcomes. Monocytes (MOs) and macrophages, largely associated with arthritis, are contributors and sensors of inflammation through epigenetic modifications. [...]
2022 - 10.1172/jci.insight.158783
JCI Insight, Vol. 7 Núm. 9 (september 2022) , p. e158783  

Depósito Digital de Documentos de la UAB : Encontrados 36 registros   1 - 10siguientefinal  ir al registro:
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.